← Open Payments lookup

LACEY LICHTENSTEIN: Open Payments

NPI 1720477714 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$319 in 17 payments from 9 companies in 2025. Trend: 2023 $343 · 2024 $376 · 2025 $319

Food & beverage: $319
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.6$99
Novartis Pharmaceuticals Corporation3$54
UROGEN PHARMA, INC.2$45
ABBVIE INC.1$27
TOLMAR, INC.1$21
Bayer Healthcare Pharmaceuticals Inc.1$20
Dendreon Pharmaceuticals LLC1$20
Ferring Pharmaceuticals Inc.1$17
COLOPLAST CORP1$16

Products named: GEMTESA, PLUVICTO, BOTOX, ELIGARD, Nubeqa, PROVENGE, ADSTILADRIN, Titan.

Industry payments across MS — which companies pay providers there.